RSLS logo

ReShape Lifesciences Inc. (RSLS)

Profile

Full Name

ReShape Lifesciences Inc.

Ticker

NASDAQ: RSLS

Exchange

NASDAQ

Country

United States

IPO

October 6, 2016

Indexes

Not included

Employees

17

Key Details

Price

$15.68

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$8.01M(-7.74% YoY)

Annual EPS

-$345.75(-212.11% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
See Full Chart & Historical Data

Analyst ratings

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price Performance

Price Range

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Shares Outstanding

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

EPS

Profit

Expenses

EBIT & EBITDA

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Liabilities

Debt

Equity & Capital

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

CAPEX

Free Cash Flow

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

ROA & ROE

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Analyst ratings

Recent major analysts updates

Jul 17, 24 Maxim Group
Hold
May 26, 22 Alliance Global Partners
Buy
Oct 8, 21 Maxim Group
Buy

Institutional Ownership

Screeners with RSLS included

No data
  • What is the ticker symbol for ReShape Lifesciences Inc.?
  • Does ReShape Lifesciences Inc. pay dividends?
  • What sector is ReShape Lifesciences Inc. in?
  • What industry is ReShape Lifesciences Inc. in?
  • What country is ReShape Lifesciences Inc. based in?
  • When did ReShape Lifesciences Inc. go public?
  • Is ReShape Lifesciences Inc. in the S&P 500?
  • Is ReShape Lifesciences Inc. in the NASDAQ 100?
  • Is ReShape Lifesciences Inc. in the Dow Jones?
  • When was ReShape Lifesciences Inc.'s last earnings report?
  • When does ReShape Lifesciences Inc. report earnings?

What is the ticker symbol for ReShape Lifesciences Inc.?

The ticker symbol for ReShape Lifesciences Inc. is NASDAQ:RSLS

Does ReShape Lifesciences Inc. pay dividends?

No, ReShape Lifesciences Inc. does not pay dividends

What sector is ReShape Lifesciences Inc. in?

ReShape Lifesciences Inc. is in the Healthcare sector

What industry is ReShape Lifesciences Inc. in?

ReShape Lifesciences Inc. is in the Medical Devices industry

What country is ReShape Lifesciences Inc. based in?

ReShape Lifesciences Inc. is headquartered in United States

When did ReShape Lifesciences Inc. go public?

ReShape Lifesciences Inc.'s initial public offering (IPO) was on October 6, 2016

Is ReShape Lifesciences Inc. in the S&P 500?

No, ReShape Lifesciences Inc. is not included in the S&P 500 index

Is ReShape Lifesciences Inc. in the NASDAQ 100?

No, ReShape Lifesciences Inc. is not included in the NASDAQ 100 index

Is ReShape Lifesciences Inc. in the Dow Jones?

No, ReShape Lifesciences Inc. is not included in the Dow Jones index

When was ReShape Lifesciences Inc.'s last earnings report?

ReShape Lifesciences Inc.'s most recent earnings report was on August 14, 2025

When does ReShape Lifesciences Inc. report earnings?

The date for ReShape Lifesciences Inc.'s next earnings report has not been announced yet
On this page